For example, mutations in genes such as PTEN, SMAD2, TGFB2, and SRC implicated in epithelial-mesenchymal transition, metastasis, and cancer progression [40, 41], were enriched in more aggressive groups while the other genes clustered in the less aggressive groups. This evidence concerns the gene PTEN and cancer.